U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research | CDER
  5. Division of Non-Prescription Drugs and Health Fraud
  1. Center for Drug Evaluation and Research | CDER

Division of Non-Prescription Drugs and Health Fraud

 

Director: John (Brad) Pace, J.D., (acting)

Branch Chief, Over-the-Counter Drugs Branch: Tina Walther Smith, M.S.

Branch Chief, Health Fraud and Consumer Outreach Branch: Vacant

The Division of Non-Prescription Drugs and Health Fraud (DNPDHF) directs field inspections and investigations and recommends, directs and/or coordinates case development and compliance actions related to both fraudulent drug products and OTC drug products.  In addition, DNPDF provides enforcement and litigation support and guidance relating to these products.   

DNPDHF uses risk-based assessments to identify and prioritize fraudulent and OTC drug products for regulatory action and develops compliance strategies to address violations.  DNPDHF also reviews and develops legislative proposals and implements regulations, policy documents, enforcement strategies, and outreach activities related to these drug products.
 

For additional information, please visit:

 

Back to Top